These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1513328)

  • 1. Evidence for the stereoselective inhibition of chick embryo hepatic ferrochelatase by N-alkylated porphyrins. II.
    Kimmett SM; Whitney RA; Marks GS
    Mol Pharmacol; 1992 Aug; 42(2):307-10. PubMed ID: 1513328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the stereoselective inhibition of chick embryo hepatic ferrochelatase by N-alkylated porphyrins.
    McCluskey SA; Whitney RA; Marks GS
    Mol Pharmacol; 1989 Oct; 36(4):608-14. PubMed ID: 2811858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of N-vinylprotoporphyrin IX after hepatic cytochrome P450 inactivation by 3-[(arylthio)ethyl]sydnone in chick embryos pretreated with phenobarbital, glutethimide, dexamethasone, and beta-naphthoflavone: differential inhibition of ferrochelatase by N-vinylprotoporphyrin regioisomers.
    Kimmett SM; Whitney RA; Marks GS
    Mol Pharmacol; 1996 Apr; 49(4):676-82. PubMed ID: 8609896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibition of hepatic ferrochelatase by regioisomers of N-butyl-, N-pentyl-, N-hexyl-, and N-isobutylprotoporphyrin IX.
    McCluskey SA; Marks GS; Whitney RA; Ortiz de Montellano PR
    Mol Pharmacol; 1988 Jul; 34(1):80-6. PubMed ID: 3393143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of regioisomers of N-alkylprotoporphyrin IX from chick embryo liver after treatment with porphyrinogenic xenobiotics.
    Kobus SM; Wong SG; Marks GS
    Can J Physiol Pharmacol; 2001 Sep; 79(9):814-21. PubMed ID: 11599783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thin-layer chromatographic separation of the ferrochelatase-inhibitory ring A and ring B regioisomers of N-ethylprotoporphyrin from a mixture of the four regioisomers.
    Kimmett SM; Marks GS
    J Pharmacol Toxicol Methods; 1992 Sep; 28(2):113-7. PubMed ID: 1482786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 and its interactions with the heme biosynthetic pathway.
    De Matteis F; Marks GS
    Can J Physiol Pharmacol; 1996 Jan; 74(1):1-8. PubMed ID: 8963944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferrochelatase-inhibitory activity and N-alkylprotoporphyrin formation with analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine (DDC) containing extended 4-alkyl groups: implications for the active site of ferrochelatase.
    McCluskey SA; Marks GS; Sutherland EP; Jacobsen N; Ortiz de Montellano PR
    Mol Pharmacol; 1986 Oct; 30(4):352-7. PubMed ID: 3762522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of an N-alkylprotoporphyrin IX from chick embryo livers following the administration of 3,5-diethoxycarbonyl-1,4-dihydro-4-ethyl-2,6-dimethylpyridine.
    McCluskey SA; Sutherland EP; Racz WJ; Marks GS
    Can J Physiol Pharmacol; 1987 Jul; 65(7):1500-2. PubMed ID: 3664364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,2-Dialkyl-1,2-dihydroquinolines: cytochrome P-450 catalyzed N-alkylporphyrin formation, ferrochelatase inhibition, and induction of 5-aminolevulinic acid synthase activity.
    Lukton D; Mackie JE; Lee JS; Marks GS; Ortiz de Montellano PR
    Chem Res Toxicol; 1988; 1(4):208-15. PubMed ID: 2979733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suicidal destruction of cytochrome P-450 and reduction of ferrochelatase activity by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells.
    Marks GS; Allen DT; Johnston CT; Sutherland EP; Nakatsu K; Whitney RA
    Mol Pharmacol; 1985 Apr; 27(4):459-65. PubMed ID: 3982391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P4503A is the major source of N-vinylprotoporphyrin IX formation after administration of 3-[2-(2,4,6-trimethylphenyl)thioethyl]-4-methylsydnone to untreated and dexamethasone-pretreated rats.
    McNamee JP; Marks GS
    Drug Metab Dispos; 1996 Aug; 24(8):872-8. PubMed ID: 8869822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of inhibition of ferrochelatase by N-methylprotoporphyrin.
    Shi Z; Ferreira GC
    Biochem J; 2006 Oct; 399(1):21-8. PubMed ID: 16792525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibition of hepatic ferrochelatase by the isomers of N-ethylprotoporphyrin IX.
    Ortiz de Montellano PR; Kunze KL; Cole SP; Marks GS
    Biochem Biophys Res Commun; 1981 Nov; 103(2):581-6. PubMed ID: 7332558
    [No Abstract]   [Full Text] [Related]  

  • 15. The apoprotein of cytochrome P450 3A2 does not selectively direct alkylation to one of four pyrrole rings of N-vinylprotoporphyrin IX.
    McNamee JP; Kobus SM; Marks GS
    Can J Physiol Pharmacol; 1996 Aug; 74(8):996-1000. PubMed ID: 8960390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of ferrochelatase by N-methylprotoporphyrin IX is not accompanied by delta-aminolevulinic acid synthetase induction in chick embryo liver cell culture.
    Cole SP; Marks GS; Oritz de Montellano PR; Kunze KL
    Can J Physiol Pharmacol; 1982 Feb; 60(2):212-5. PubMed ID: 6896292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hepatic ferrochelatase by the four isomers of N-methylprotoporphyrin IX.
    Ortiz de Montellano PR; Kunze KL; Cole SP; Marks GS
    Biochem Biophys Res Commun; 1980 Dec; 97(4):1436-42. PubMed ID: 6894236
    [No Abstract]   [Full Text] [Related]  

  • 18. Metallation of the transition-state inhibitor N-methyl mesoporphyrin by ferrochelatase: implications for the catalytic reaction mechanism.
    Shipovskov S; Karlberg T; Fodje M; Hansson MD; Ferreira GC; Hansson M; Reimann CT; Al-Karadaghi S
    J Mol Biol; 2005 Oct; 352(5):1081-90. PubMed ID: 16140324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the inhibition of ferrochelatase by N-alkylated dicarboxylic porphyrins. Steric factors involved and evidence that the inhibition is reversible.
    De Matteis F; Gibbs AH; Harvey C
    Biochem J; 1985 Mar; 226(2):537-44. PubMed ID: 3838893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and mechanistic basis of porphyrin metallation by ferrochelatase.
    Lecerof D; Fodje M; Hansson A; Hansson M; Al-Karadaghi S
    J Mol Biol; 2000 Mar; 297(1):221-32. PubMed ID: 10704318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.